Overview

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to measure the prevention of lipoatrophy in patients treated with Lopinavir/R in monotherapy versus ZDV + 3TC + ABC
Phase:
Phase 4
Details
Lead Sponsor:
Fundacion SEIMC-GESIDA
Collaborator:
Abbott
Treatments:
Lopinavir